Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
Bethan L. Clifford, Leslie R. Sedgeman, Kevin J. Williams, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1671-1684.e4
Open Access | Times Cited: 276

Showing 1-25 of 276 citing articles:

Bile acid metabolism and signaling, the microbiota, and metabolic disease
Jingwei Cai, Bipin Rimal, Changtao Jiang, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108238-108238
Open Access | Times Cited: 203
Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease
Yoon Mee Yang, Ye Eun Cho, Seonghwan Hwang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 774-774
Open Access | Times Cited: 132
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
Delilah Hendriks, Jos F. Brouwers, Karien M. Hamer, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 11, pp. 1567-1581
Open Access | Times Cited: 99
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
Tingying Jiao, Yuandi Ma, Xiaozhen Guo, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 5, pp. 1103-1119
Open Access | Times Cited: 72
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
Jiaqiang Wu, Kangping Yang, Hancheng Fan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 58
Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy
Bo Tang, Li Tang, Shengpeng Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis
Jia Wang, Yitao Li, Kenneth Cheung, et al.
Science China Life Sciences (2023) Vol. 67, Iss. 5, pp. 865-878
Closed Access | Times Cited: 54
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé‐Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 47
NAFLD and NASH: etiology, targets and emerging therapies
Shulin Wei, Lianzhou Wang, Paul C. Evans, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103910-103910
Closed Access | Times Cited: 40
Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids
Chang Liu, Meng‐Xuan Du, Lisheng Xie, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 434-450
Closed Access | Times Cited: 30
Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification
Haiyuan Shen, Liangliang Zhou, Hao Zhang, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 8, pp. 1331-1346.e6
Closed Access | Times Cited: 19
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease
Shixuan Jiao, Qiang Ren, Lianru Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Disentangling Organ‐Specific Roles of Farnesoid X Receptor in Bile Acid and Glucolipid Metabolism
Tingting Li, Chenyang Fu, Zhongzheng Tang, et al.
Liver International (2025) Vol. 45, Iss. 4
Open Access | Times Cited: 1
The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
Ting Hong, Yiyan Chen, M Kellis, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 67
Emerging targetome and signalome landscape of gut microbial metabolites
Xiao Zheng, Xiaoying Cai, Haiping Hao
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 35-58
Open Access | Times Cited: 59
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH
Vlad Ratziu, Stephen A. Harrison, V. Loustaud‐Ratti, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 479-492
Open Access | Times Cited: 53
Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor
Wenjing Xu, Changting Cui, Chunmei Cui, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1794-1810
Open Access | Times Cited: 51
Blood ethylene oxide, systemic inflammation, and serum lipid profiles: Results from NHANES 2013–2016
Xu Zhu, Xiangying Kong, Mengli Chen, et al.
Chemosphere (2022) Vol. 299, pp. 134336-134336
Closed Access | Times Cited: 39
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
Tingyu Fang, Hua Wang, Xiaoyue Pan, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5681-5697
Open Access | Times Cited: 38
Rational combination therapy for NASH: Insights from clinical trials and error
Vlad Ratziu, Michael Charlton
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 1073-1079
Open Access | Times Cited: 35
Hepatic nonvesicular cholesterol transport is critical for systemic lipid homeostasis
Xiao Xu, John P. Kennelly, Alessandra Ferrari, et al.
Nature Metabolism (2023) Vol. 5, Iss. 1, pp. 165-181
Open Access | Times Cited: 35
Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia
Hongtao Xu, Fang Fang, Kaizhang Wu, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 34
Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation
Tingting Yang, Yiying Wang, Xinyun Cao, et al.
Phytomedicine (2023) Vol. 113, pp. 154703-154703
Closed Access | Times Cited: 30
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top